JNJ250110P138000
- 0.04
- +0.03+300.00%
Johnson & Johnson Newsroom
Wells Fargo Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $166
Bernstein Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Cuts Target Price to $160
Bernstein Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Raises Target Price to $177
Johnson & Johnson (JNJ) Gets a Hold From Bernstein
Morgan Stanley Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $175
RBC Capital Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $181
Bernstein Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $161
Morgan Stanley Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $175
RBC Capital Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $181
Bank of America resumes coverage of Johnson & Johnson with a Target Price of $166.
Johnson & Johnson Analyst Ratings
Citi Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Cuts Target Price to $175
Johnson & Johnson Analyst Ratings
B of A Securities Reinstates Neutral on Johnson & Johnson, Announces $166 Price Target
Wells Fargo Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $166
Morgan Stanley Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $175
Johnson & Johnson Initiated at Outperform by Wolfe Research
Johnson & Johnson Analyst Ratings
Wolfe Research Upgrades Johnson & Johnson(JNJ.US) to Buy Rating, Raises Target Price to $190
Johnson & Johnson Analyst Ratings